Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2009-1-19
pubmed:abstractText
Levodopa induced dyskinesias (LID) are a common problem which ultimately limit the effective treatment of patients with Parkinson's disease (PD). There is accumulating evidence that LID develop due to abnormal synaptic plasticity, which is in turn influenced by the release of brain derived neurotrophic factor (BDNF).
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1468-330X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
141-4
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:18977816-Adult, pubmed-meshheading:18977816-Aged, pubmed-meshheading:18977816-Alleles, pubmed-meshheading:18977816-Antiparkinson Agents, pubmed-meshheading:18977816-Brain-Derived Neurotrophic Factor, pubmed-meshheading:18977816-Corpus Striatum, pubmed-meshheading:18977816-Dyskinesia, Drug-Induced, pubmed-meshheading:18977816-Female, pubmed-meshheading:18977816-Gene Expression, pubmed-meshheading:18977816-Genotype, pubmed-meshheading:18977816-Humans, pubmed-meshheading:18977816-Levodopa, pubmed-meshheading:18977816-Male, pubmed-meshheading:18977816-Middle Aged, pubmed-meshheading:18977816-Neuronal Plasticity, pubmed-meshheading:18977816-Parkinson Disease, pubmed-meshheading:18977816-Polymorphism, Genetic, pubmed-meshheading:18977816-Receptor, trkB, pubmed-meshheading:18977816-Risk Factors, pubmed-meshheading:18977816-Synapses, pubmed-meshheading:18977816-Time Factors
pubmed:year
2009
pubmed:articleTitle
BDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease.
pubmed:affiliation
Cambridge Centre for Brain Repair, Cambridge, UK. T.Foltynie@ion.ucl.ac.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't